Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer.

Cancer causes & control : CCC

Volumn 24, Issue 12, 2013, Pages 2197-2206

  Faber, M T ^a   Jensen, A ^a   Frederiksen, K ^a   Glud, E ^b   Hogdall E ^a,c   Hogdall C ^d   Blaakaer J ^e   Kjaer S K ^a,d  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b HILLERØD HOSPITAL   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; DENMARK; FEMALE; FOLLOW UP; HUMAN; MIDDLE AGED; OVARY TUMOR; PROGNOSIS; RISK FACTOR;

ADULT; AGED; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; DENMARK; ESTROGENS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PROGESTINS; PROGNOSIS; RISK FACTORS;

EID: 84902641201     PISSN: None     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-013-0296-8     Document Type: Article

References (0)